MDRC Regional Pilot/Feasibility Grant Program

  Applications Due: Wednesday, August 4, 2021 (11:59 PM ET)

The Regional Pilot/Feasibility (P/F) Grant Program is sponsored by the Michigan Diabetes Research Center (MDRC). Its purpose is to promote research in diabetes by new and established Wayne State University, Michigan State University, and University of Toledo faculty, and to promote collaboration among investigators at these regional institutions and MDRC members at The University of Michigan. The ultimate goal of the program is to enhance regional communication and collaboration among diabetes investigators, accelerate the pace of research, and enable awardees to generate sufficient preliminary data for successful applications for major research funding from the NIH or other national granting agency.  
Grant proposals may be in the areas of basic biomedical or clinical (Type T1 translational, bench to bedside) research and should address key questions regarding the pathogenesis, diagnosis, prevention, or treatment of diabetes, its complications, or related endocrine or metabolic disorders (for example: obesity, metabolic syndrome, counter-regulatory proteins).

Individuals who hold instructional, research or clinical faculty positions at Wayne State University, Michigan State University, and University of Toledo are eligible to apply as Principal Investigators of Regional P/F proposals. Eligible applicants are: a) new investigators beginning careers in diabetes-related research; b) established investigators who have not previously worked in diabetes research but wish to focus their expertise on diabetes; or c) established diabetes investigators who propose innovative research in diabetes that represents a clear departure from their ongoing research.  This new direction cannot be an extension or outgrowth of research currently being undertaken by the applicant.  Priority is given to investigators in category “a” followed by investigators in category “b”.   

Regional P/F proposals should be for one year of support, with requested funding up to $60,000 (University of Toledo, Michigan State University) or $70,000 (Wayne State University) direct costs.
Each proposal will receive extramural peer review by recognized experts in the area of the proposal from the United States and abroad. Revised proposals from previous cycles are considered new applications and will be reviewed as such. The MDRC Grants Program Advisory Council of expert investigators reviews the P/F applications together with their respective peer evaluations and ranks the applications based on scientific merit and relevancy to diabetes research before final funding decisions are made. Funding of Regional P/F grants that receive favorable review is anticipated to begin December 1, 2021. 
Regional P/F grant awardees are queried annually by MDRC administrative staff and are required to provide information on the publications and funding that stem from the Regional P/F grant as this information must be reported to NIH. Regional P/F grant awardees are also expected to present their research at the MDRC Annual Diabetes Symposium. If awarded funding, junior faculty will need to identify a mentor and investigators outside the diabetes field will need to identify a diabetes advisor.  
  • Visit for the Regional Pilot/Feasibility (P/F) Grant Program application in Competition Space.
  • Download the Regional P/F Application and other Required Application Materials located on the right-hand side of the page under Competition Files. The Regional P/F Application file contains detailed application instructions.
  • When you are ready to submit your application, select “Apply” from the right-hand menu in this Competition Space opportunity.
  • All details are automatically saved as you enter them. When you are ready to submit, click "Submit Application" at the bottom of the page. You will receive a confirmation email once your application has been submitted.

Questions: Please contact Sarah Cain,

Remember to cite the Michigan Diabetes Research Center (MDRC) in publications as follows:
“The project described was supported by Grant Number P30DK020572 (MDRC) from the National Institute of Diabetes and Digestive and Kidney Diseases”